FierceBiotechOriginal article
{"a":[{"_":"Novo Nordisk pens long-acting GLP-1 implant tech deal with Vivani Medical","$":{"href":"/medtech/novo-nordisk-pens-glp-1-long-acting-implant-tech-deal-vivani-medical","hreflang":"en"}}]}
PartnershipsemaglutidePositive
AI Analysis
Summary
Novo Nordisk has entered into a partnership with Vivani Medical to develop long-acting GLP-1 implant technology to expand its semaglutide franchise.
Importance:6/10
Sentiment:
0.50
partnershipGLP-1semaglutideimplantlong-actingNovo NordiskVivani Medical
Related Companies
Read the original article
Published by FierceBiotech on July 7, 2026 8:53 AM